An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

Cited by (1,001)

Items 801–900 of 1,001

1. EGFR mutations and abnormal trafficking in cancers
   Kang Xiang, Rendong Li, Xiaolei Li, Xinping Xu · 2024 · Molecular Biology Reports
2. Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2
   Martiniano Bello, Lucia Saldaña-Rivera, José Correa‐Basurto, Juan Benjamín García-Vázquez, Víctor Armando Sánchez-Espinosa · 2018 · International Journal of Biological Macromolecules
3. Evolution of Functional Diversity in the Holozoan Tyrosine Kinome
   Wayland Yeung, Annie Kwon, Rahil Taujale, Claire Bunn, Aarya Venkat, Natarajan Kannan · 2021 · Molecular Biology and Evolution
4. Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation
   Raphael Trenker, Devan C. Diwanji, Tanner Bingham, Kliment A. Verba, Natalia Jura · 2023 · eLife
5. Lipid-anchored proteasomes control membrane protein homeostasis
   Ruizhu Zhang, S Pan, Suya Zheng, Qingqing Liao, Zhaodi Jiang, Di-Xian Wang, Xuemei Li, Ao Hu, Xinran Li, Yezhang Zhu et al. · 2023 · Science Advances
6. Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression
   Seungchan Yang, Kyungho Park, James Turkson, Carlos L. Arteaga · 2007 · Experimental Cell Research
7. Protein flexibility: coordinate uncertainties and interpretation of structural differences
   Alexander A. Rashin, Abraham H. L. Rashin, Robert L. Jernigan · 2009 · Acta Crystallographica Section D Biological Crystallography
8. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain
   Lijuan He, Nadia Shobnam, Kalina A. Hristova · 2010 · Biochimica et Biophysica Acta (BBA) - Biomembranes
9. A Water-Based Mechanism of Specificity and Resistance for Lapatinib with ErbB Family Kinases
   Yulin Huang, Robert C. Rizzo · 2012 · Biochemistry
10. Computational and Experimental Characterization of Patient Derived Mutations Reveal an Unusual Mode of Regulatory Spine Assembly and Drug Sensitivity in EGFR Kinase
    Zheng Ruan, Samiksha Katiyar, Natarajan Kannan · 2016 · Biochemistry
11. Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors
    Christopher C. Valley, Andrew K. Lewis, Jonathan N. Sachs · 2017 · Biochimica et Biophysica Acta (BBA) - Biomembranes
12. Targeting kinase signaling pathways with constrained peptide scaffolds
    Laura E. Hanold, Melody D. Fulton, Eileen J. Kennedy · 2017 · Pharmacology & Therapeutics
13. Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer
    Nele Van Der Steen, Elisa Giovannetti, Daniela Carbone, Alessandro Leonetti, Christian Diego Rolfo, Godefridus J. Peters · 2018 · Cancer Drug Resistance
14. Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells
    Vehary A. Sakanyan, Marie Angelini, Mickael Le Béchec, Michèle Lecocq, Florence Benaiteau, Bénédicte Rousseau, Aram Gyulkhandanyan, Lusine Gyulkhandanyan, Cédric Logé, Éric Reiter et al. · 2014 · Scientific Reports
15. In silico profiling of tyrosine kinases binding specificity and drug resistance using Monte Carlo simulations with the ensembles of protein kinase crystal structures
    Gennady M. Verkhivker · 2006 · Biopolymers
16. A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
    Christopher E. Whitehead, Elizabeth K. Ziemke, Christy L. Frankowski-McGregor, Rachel A. Mumby, June Chung, Jinju Li, Nathaniel Osher, Oluwadara Coker, Veerabhadran Baladandayuthapani, Scott Kopetz et al. · 2024 · Nature Cancer
17. The dependence of EGFR oligomerization on environment and structure: A camera-based N&B study
    Harikrushnan Balasubramanian, Jagadish Sankaran, Shambhavi Pandey, Corinna Jie Hui Goh, Thorsten Wohland · 2022 · Biophysical Journal
18. AREG Upregulation in Cancer Cells via Direct Interaction with Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression Through EGFR-Erk/p38 MAPK Signaling
    Takashi Nakanishi, Yu‐ichiro Koma, Shoji Miyako, Rikuya Torigoe, Hiroki Yokoo, Masaki Omori, Keitaro Yamanaka, Nobuaki Ishihara, Shuichi Tsukamoto, Takayuki Kodama et al. · 2024 · Cells
19. Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases
    Andrew Shih, Shannon Telesco, Ravi Radhakrishnan · 2011 · Cancers
20. PINK1 rendered temperature sensitive by disease-associated and engineered mutations
    Derek P. Narendra, Chunxin Wang, Richard J. Youle, John E. Walker · 2013 · Human Molecular Genetics
21. Highly sensitive and noninvasive detection of epidermal growth factor receptor T790M mutation in non-small cell lung cancer
    Chen He, Lixia Zheng, Yuzhong Xu, Ming Liu, Yuanguang Li, Jun Xu · 2013 · Clinica Chimica Acta
22. Necdin controls EGFR signaling linked to astrocyte differentiation in primary cortical progenitor cells
    Izumi Fujimoto, Koichi Hasegawa, Kazushiro Fujiwara, Masashi Yamada, Kazuaki Yoshikawa · 2015 · Cellular Signalling
23. Mapping the functional versatility and fragility of Ras GTPase signaling circuits through in vitro network reconstitution
    Scott M. Coyle, Wendell A. Lim · 2016 · eLife
24. Relief of autoinhibition by conformational switch explains enzyme activation by a catalytically dead paralog
    Oleg A. Volkov, Lisa N. Kinch, Carson Ariagno, Xiaoyi Deng, Shihua Zhong, Nick V. Grishin, Diana R. Tomchick, Zhe Chen, Margaret A. Phillips · 2016 · eLife
25. Optical measurement of receptor tyrosine kinase oligomerization on live cells
    Inhee Chung · 2017 · Biochimica et Biophysica Acta (BBA) - Biomembranes
26. Assembly of the Sos1–Grb2–Gab1 ternary signaling complex is under allosteric control
    Caleb B. McDonald, Kenneth Ladd Seldeen, Brian J. Deegan, Vikas S. Bhat, Amjad Farooq · 2009 · Archives of Biochemistry and Biophysics
27. Adaptability in protein structures: structural dynamics and implications in ligand design
    Atanu Maity, Sarmistha Majumdar, Prerna Priya, Pallavi De, Sudipto Saha, Shubhra Ghosh Dastidar · 2014 · Journal of Biomolecular Structure and Dynamics
28. Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains
    Tímea Hajdu, Tímea Váradi, István Rebenku, Tamás Kovács, János Szöllõsi, Péter Nagy · 2020 · Frontiers in Cell and Developmental Biology
29. Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers
    Vidhi Malik, Vipul Kumar, Sunil C. Kaul, Renu Wadhwa, Durai Sundar · 2021 · Biomolecules
30. Genotype-determined EGFR-RTK heterodimerization and its effects on drug resistance in lung Cancer treatment revealed by molecular dynamics simulations
    Mengxu Zhu, Debby D. Wang, Hong Yan · 2021 · BMC Molecular and Cell Biology
31. The stability of R-spine defines RAF inhibitor resistance: A comprehensive analysis of oncogenic BRAF mutants with in-frame insertion of αC-β4 loop
    Jiajun Yap, R. N. V. Krishna Deepak, Zizi Tian, Wan Hwa Ng, Kah Chun Goh, Alicia Foo, Zi Heng Tee, Manju Payini Mohanam, Yuen Rong M. Sim, Ufuk Degirmenci et al. · 2021 · Science Advances
32. Design of novel cyanovirin-N variants by modulation of binding dynamics through distal mutations
    Kazan, I Can, Sharma, Prerna, Rahman, Mohammad Imtiazur, Bobkov, Andrey, Fromme, Raimund, Ghirlanda, Giovanna, Ozkan, S Banu · 2022 · eLife
33. Computational investigation of Moringa oleifera phytochemicals targeting EGFR: molecular docking, molecular dynamics simulation and density functional theory studies
    Muhammad Abrar Yousaf, Sadia Anjum Anwer, Shefin Basheera, Sreekumar Sivanandan · 2023 · Journal of Biomolecular Structure and Dynamics
34. Molecular basis of VEGFR1 autoinhibition at the plasma membrane
    Manas Pratim Chakraborty, Diptatanu Das, Purav Mondal, Pragya Kaul, Soumi Bhattacharyya, Prosad Kumar Das, Rahul Das · 2024 · Nature Communications
35. Transphosphorylation of EGFR at Y845 plays an important role in its autophosphorylation and kinase activity
    Hui Song, Lei Haley Huang, MING ZHANG, Xiuwei Wang, SHUANG SONG, Lin Yang · 2014 · Oncology Reports
36. Ligand binding induces a conformational change in epidermal growth factor receptor dimers
    Francesca Walker, Julie Rothacker, Christine A. Henderson, Edouard Collins Nice, Bruno Catimel, Huihua Zhang, Andrew Mark Scott, Michael F. Bailey, Suzanne Gaye Orchard, Timothy E. Adams et al. · 2012 · Growth Factors
37. Principles and characteristics of biological assemblies in experimentally determined protein structures
    Qifang Xu, Roland L. Dunbrack · 2019 · Current Opinion in Structural Biology
38. Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
    Masami Nozaki, Hiroki Yasui, Yuichi Ohnishi · 2019 · Cancers
39. Pseudokinases: From Allosteric Regulation of Catalytic Domains and the Formation of Macromolecular Assemblies to Emerging Drug Targets
    Andrada Tomoni, Jonathan Gill Lees, Andrés G. Santana, Víctor M. Bolaños-García, Ágatha Bastida · 2019 · Catalysts
40. Current Challenges and Future Directions
    David Matthews, Mary E. Gerritsen · 2010
41. Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers
    Marcia R. Campbell, Ana Ruiz-Sáenz, Elliott Peterson, Christopher Agnew, Pelin Ayaz, Samuel E. Garfinkle, Peter Littlefield, Veronica Steri, Julie Oeffinger, Maryjo Sampang et al. · 2022 · Cell Reports
42. Structure-based pharmacophore mapping and virtual screening of natural products to identify polypharmacological inhibitor against c-MET/EGFR/VEGFR-2
    Diksha A. Varma, Mrityunjay Singh, Sharad Ramesh Wakode, N. E. Dinesh, Simran Vinaik, Shailendra Asthana, Manisha Tiwari · 2022 · Journal of Biomolecular Structure and Dynamics
43. Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects
    Avinash D. Khadela, Yesha B. Shah, Priya S. Mistry, Kunjan Bharatbhai Bodiwala, Avinash CB · 2023 · Technology in Cancer Research & Treatment
44. The Ys and wherefores of protein kinase autoinhibition
    Richard W. Bayliss, Tamanna Haq, Sharon Yeoh · 2015 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
45. Activating Mutations Cluster in the “Molecular Brake” Regions of Protein Kinases and Do Not Associate with Conserved or Catalytic Residues
    Miguel Ángel Molina‐Vila, Núria Nabau-Moretó, Cristian Tornador, Amit J. Sabnis, Rafael Rosell, Xavier Estivill, Trever Grant Bivona, Cristina Marino‐Buslje · 2013 · Human Mutation
46. Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
    Ninnutt Moonrin, Napat Songtawee, Siriluk Rattanabunyong, Surasuk Chunsrivirot, Wanwimon Mokmak, Sissades Tongsima, Kiattawee Choowongkomon · 2015 · BMC Bioinformatics
47. Studying the Conformation of a Receptor Tyrosine Kinase in Solution by Inhibitor‐Based Spin Labeling
    Dongsheng M. Yin, Jeffrey S. Hannam, Anton Schmitz, Olav Schiemann, Gregor Hagelueken, Michael Famulok · 2017 · Angewandte Chemie International Edition
48. Discovery of 3,3a,4,5-tetrahydro-2H-benzo[g]indazole containing quinoxaline derivatives as novel EGFR/HER-2 dual inhibitors
    Xi Zong, Jin Cai, Junqing Chen, Chunlong Sun, Lushen Li, Min Ji · 2015 · RSC Advances
49. Structural investigation of deleterious non-synonymous SNPs of EGFR gene
    Dhwani Raghav, Vinay Sharma, Subhash Mohan Agarwal · 2013 · Interdisciplinary Sciences Computational Life Sciences
50. Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain
    Byram Hirsch Ozer, Gregory J. Wiepz, Paul J. Bertics · 2009 · Oncogene
51. p38α MAP Kinase Dimers with Swapped Activation Segments and a Novel Catalytic Loop Conformation
    Ulli Rothweiler, Espen Åberg, Kenneth Alan Johnson, Tom E. Hansen, Jorunn B. Jørgensen, Richard Alan Engh · 2011 · Journal of Molecular Biology
52. New therapeutic strategies targeting transmembrane signal transduction in the immune system
    Alexander B. Sigalov · 2010 · Cell Adhesion & Migration
53. The activating role of phospho-(Tyr)-calmodulin on the epidermal growth factor receptor
    Silviya R. Stateva, Valentina Salas, Alberto Benguría, Itziar Cossío, Estefanía Anguita, José Martín‐Nieto, Gustavo Benaím, Antonio Villalobo · 2015 · Biochemical Journal
54. Mutual cross-talk between fibronectin integrins and the EGF receptor
    Nikolas G. Balanis, Cathleen R. Carlin · 2012 · Cellular Logistics
55. EGFR inhibitors across generations: Progress, challenges, and future directions
    Vishal G. Deshmukh, Suryakant B. Sapkal, Suchita S. Gadekar, Vaishali Deshmukh · 2025 · Journal of Molecular Structure
56. Analysis of Epidermal Growth Factor Receptor Dimerization by BS3 Cross-Linking
    Harmony F. Turk, Robert S. Chapkin · 2014 · Methods in molecular biology
57. Cell Adhesion Molecules as Modulators of the Epidermal Growth Factor Receptor
    Irina Kozlova, Vladimir Sytnyk · 2024 · Cells
58. Un regard simple sur la biologie du cancer bronchique : MET
    Anne-Marie Ruppert, Michèle Beau‐Faller, Laure Belmont, A. Lavolé, Valérie Gounant, Jacques L. Cadranel, Marie Wislez · 2011 · Revue des Maladies Respiratoires
59. Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay
    F. Barros, Tarek M. A. Abdel-Fatah, Paul M. Moseley, Christopher C. Nolan, Alice C. Durham, Emad A. Rakha, Stephen Y.T. Chan, Ian Ogilvie Ellis, Andrew R. Green · 2014 · Breast Cancer Research and Treatment
60. Functional and structural characterization of the kinase insert and the carboxy terminal domain in VEGF receptor 2 activation
    Sandro Manni, Kaisa Kisko, Thomas Schleier, Jack Missimer, Kurt Ballmer‐Hofer · 2014 · The FASEB Journal
61. Uncovering homo-and hetero-interactions on the cell membrane using single particle tracking approaches
    Juan Andres Torreno-Pina, Carlo Manzo, M.F. Garcia Parajo · 2016 · Journal of Physics D Applied Physics
62. Modeling the effect of pathogenic mutations on the conformational landscape of protein kinases
    Giorgio Saladino, Francesco Luigi Gervasio · 2016 · Current Opinion in Structural Biology
63. Hydrogen Exchange Differences between Chemoreceptor Signaling Complexes Localize to Functionally Important Subdomains
    Seena Koshy, Xuni Li, Stephen J. Eyles, Robert M. Weis, Lynmarie K. Thompson · 2014 · Biochemistry
64. Coupled regulation by the juxtamembrane and sterile α motif (SAM) linker is a hallmark of ephrin tyrosine kinase evolution
    Annie Kwon, Mihir John, Zheng Ruan, Natarajan Kannan · 2018 · Journal of Biological Chemistry
65. Targeting protein self-association in drug design
    Léopold Thabault, Maxime Liberelle, Raphaël Frédérick · 2021 · Drug Discovery Today
66. Repurposing FDA Drug Compounds against Breast Cancer by Targeting EGFR/HER2
    Irving Balbuena-Rebolledo, Itzia Irene Padilla Martínez, Martha Cecilia Rosales‐Hernández, Martiniano Bello · 2021 · Pharmaceuticals
67. The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs
    Lung‐Yu Liang, Michael J. Roy, Christopher R. Horne, Jarrod John Sandow, Minglyanna Surudoi, Laura F. Dagley, Samuel N. Young, Toby A. Dite, Jeffrey J. Babon, Peter W. Janes et al. · 2021 · Biochemical Journal
68. Targeting the Calmodulin-Regulated ErbB/Grb7 Signaling Axis in Cancer Therapy
    Antonio Villalobo, Irene García‐Palmero, Silviya R. Stateva, Karim Jellali · 2013 · Journal of Pharmacy & Pharmaceutical Sciences
69. Geldanamycin selectively targets the nascent form of ERBB3 for degradation
    C. Sachi Gerbin, Ralf Landgraf · 2010 · Cell Stress and Chaperones
70. Exploring sequence-structure relationships in the tyrosine kinome space: functional classification of the binding specificity mechanisms for cancer therapeutics
    Gennady M. Verkhivker · 2007 · Bioinformatics
71. Dynamic Protein Allosteric Regulation and Disease
    Nussinov, Ruth, Tsai, Chung-Jung, Jang, Hyunbum · 2019 · Advances in Experimental Medicine and Biology
72. Syndecans and Their Synstatins: Targeting an Organizer of Receptor Tyrosine Kinase Signaling at the Cell-Matrix Interface
    Alan C. Rapraeger · 2021 · Frontiers in Oncology
73. Pharmacophore modeling, virtual screening, molecular docking and dynamics studies for the discovery of HER2-tyrosine kinase inhibitors: An in-silico approach
    Gurubasavaraja Swamy Purawarga Matada, Prasad Sanjay Dhiwar, Nahid Abbas, Ekta Singh, Abhishek Ghara, Rajesh B. Patil, Nulgumnalli Manjunathaiah Raghavendra · 2022 · Journal of Molecular Structure
74. The ErbB Signaling Network and Its Potential Role in Endometrial Cancer
    Androutsopoulos Georgios, Ioanna Styliara, Evgenia Zarogianni, Nadia Lazurko, George Valasoulis, Georgios Michail, Georgios Adonakis · 2023 · Epigenomes
75. An allosteric switch between the activation loop and a c-terminal palindromic phospho-motif controls c-Src function
    Hipólito Nicolás Cuesta Hernández, Julia Contreras, Pablo Soriano‐Maldonado, Jana Sánchez, Wayland Yeung, Ana Martín-Hurtado, Inés G. Muñoz, Natarajan Kannan, Marta Llimargas, Javier Muñoz et al. · 2023 · Nature Communications
76. In silico screening of epidermal growth factor receptor (EGFR) in the tyrosine kinase domain through a medicinal plant compound database
    Orathai Sawatdichaikul, Supa Hannongbua, Chak Sangma, Peter Wolschann, Kiattawee Choowongkomon · 2011 · Journal of Molecular Modeling
77. Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation
    Yiran Cai · 2011 · Oncology Reports
78. Identification of Critical Residues within the Conserved and Specificity Patches of Nerve Growth Factor Leading to Survival or Differentiation
    Sidharth Mahapatra, Hrishikesh Mehta, Sang Bum Woo, Kenneth Neet · 2009 · Journal of Biological Chemistry
79. Dynamic Transition States of ErbB1 Phosphorylation Predicted by Spatial Stochastic Modeling
    Meghan McCabe Pryor, Shalini T. Low-Nam, Ádám Halász, Diane S. Lidke, Bridget Smith Wilson, Jeremy S. Edwards · 2013 · Biophysical Journal
80. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: Deciphering the molecular basis of the kinase inhibitors selectivity
    Gennady M. Verkhivker · 2006 · Proteins Structure Function and Bioinformatics
81. Oxidation of protein-bound methionine in Photofrin-photodynamic therapy-treated human tumor cells explored by methionine-containing peptide enrichment and quantitative proteomics approach
    Ya‐Ju Hsieh, Kun‐Yi Chien, I-Fang Yang, I‐Neng Lee, Chia‐Chun Wu, Tung-Yung Huang, Jau‐Song Yu · 2017 · Scientific Reports
82. Genotyping of common EGFR mutations in lung cancer patients by electrochemical biosensor
    Xiuhua Weng, Xiongwei Xu, Changlian Wang, Wei-Wei Lin, Ai‐Lin Liu, Wei Chen, Xinhua Lin · 2017 · Journal of Pharmaceutical and Biomedical Analysis
83. A combined computational and experimental strategy identifies mutations conferring resistance to drugs targeting the BCR-ABL fusion protein
    Jinxin Liu, Jianfeng Pei, Luhua Lai · 2020 · Communications Biology
84. Autophosphorylation of EGFR at Y954 Facilitated Homodimerization and Enhanced Downstream Signals
    Ovia Margaret Thirukkumaran, M. Kluba, Johan Hofkens, Hideaki Mizuno · 2020 · Biophysical Journal
85. Allosteric Inhibition of HER2 by Moesin-Mimicking Compounds Targets HER2-Positive Cancers and Brain Metastases
    Camille Faure, Rym Djerbi-Bouillié, Anaïs Domingot, Haniaa Bouzinba-Ségard, Saı̈d Taouji, Yanis Saidi, Sandra C. Bernard, Floriane Carallis, Romy Rothe, Jean‐Luc Lenormand et al. · 2021 · Cancer Research
86. Coarse-Grained Molecular Simulation of Epidermal Growth Factor Receptor Protein Tyrosine Kinase Multi-Site Self-Phosphorylation
    John G. Koland · 2014 · PLoS Computational Biology
87. Molecular dynamics of the asymmetric dimers of EGFR: Simulations on the active and inactive conformations of the kinase domain
    Napat Songtawee, David R. Bevan, Kiattawee Choowongkomon · 2015 · Journal of Molecular Graphics and Modelling
88. The epidermal growth factor system of ligands and receptors in cancer
    William John Gullick · 2009 · European Journal of Cancer
89. Resolving the conformational dynamics of ErbB growth factor receptor dimers
    Aiswarya B. Pawar, Durba Sengupta · 2019 · Journal of Structural Biology
90. Disruption of the EGFR E884–R958 ion pair conserved in the human kinome differentially alters signaling and inhibitor sensitivity
    Zhe Tang, Shan Jiang, Ruikai Du, Edward T. Petri, A El-Telbany, P S O Chan, Takashi Kijima, Sascha Dietrich, Koji Matsui, Masashi Kobayashi et al. · 2008 · Oncogene
91. EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy
    Yuanzhuo Gu, Hongchao He, Shilei Qiao, Yifan Shao, Lurong Wang, Zhengkui Zhang, Long Zhang, Fangfang Zhou · 2025 · Advanced Science
92. Receptor tyrosine kinases (RTKs)
    Zehra Batool, Asia Azfal, Laraib Liaquat, Sadia Sadir, Rida Nisar, Aimen Inamullah, Asad Ullah Faiz Ghalib, Saida Haider · 2023 · Elsevier eBooks
93. Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
    Brigida Stanzione, Alessandro Del Conte, Elisa Bertoli, Elisa De Carlo, Alberto Revelant, Michele Spina, Alessandra Bearz · 2023 · International Journal of Molecular Sciences
94. L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab
    Ilaria Marrocco, Suvendu Giri, Arturo Simoni Nieves, Nitin Gupta, Anna Rudnitsky, Yuya Haga, Donatella Romaniello, Arunachalam Sekar, Mirie Zerbib, Roni Oren et al. · 2023 · Cell Reports Medicine
95. Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
    Wonyoung Park, Jung Ho Han, Shibo Wei, Eun-Sun Yang, Se-Yun Cheon, Sung‐Jin Bae, Dongryeol Ryu, Hwan‐Suck Chung, Ki‐Tae Ha · 2024 · International Journal of Molecular Sciences
96. In-depth biophysical analysis of interactions between therapeutic antibodies and the extracellular domain of the epidermal growth factor receptor
    Maria Leonor Alvarenga, Judith Kikhney, Jens Hannewald, Armin U. Metzger, K.‐J. Steffens, Joerg Bomke, Alexander Krah, Ansgar A. Wegener · 2011 · Analytical Biochemistry
97. A Computational Study of the Phosphorylation Mechanism of the Insulin Receptor Tyrosine Kinase
    Baojing Zhou, Chung F. Wong · 2009 · The Journal of Physical Chemistry A
98. Conformationally constrained peptides target the allosteric kinase dimer interface and inhibit EGFR activation
    Melody D. Fulton, Laura E. Hanold, Zheng Ruan, Sneha Patel, Aaron M. Beedle, Natarajan Kannan, Eileen J. Kennedy · 2017 · Bioorganic & Medicinal Chemistry
99. Studying structure and function of membrane proteins with PELDOR/DEER spectroscopy – The crystallographers’ perspective
    Janin Glaenzer, Martin F. Peter, Gregor Hagelueken · 2018 · Methods
100. Molecular mechanisms involved in epidermal growth factor receptor-mediated inhibition of dopamine D3 receptor signaling
     Ningning Sun, Xiaowei Zhang, Shuohan Guo, Hang Thi Le, Xiaohan Zhang, Kyeong‐Man Kim · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research